ACTIVE INGREDIENT: Abiraterone
STRENGTH, PACK SIZE & GMS CODE:Abiraterone Rowa 500 mg film-coated tablets x 56 ( 89220)
INDICATION:Abiraterone is indicated with prednisone or prednisolone for:
- the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mHSPC) in adult men in combination with androgen deprivation therapy (ADT) (see section 1)
- the treatment of metastatic castration resistant prostate cancer (mCRPC) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 1)
- the treatment of mCRPC in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
Please click on this link to access Abiraterone Rowa 500 mg film-coated tablets x 56 – SPC
Please click on this link to access Abiraterone Rowa 500 mg film-coated tablets x 56 – PIL